Back

Analysis of patient characteristics as covariates potentially affecting pharmacokinetics, efficacy, or safety of betrixaban in the APEX study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 6 - Best Posters in prevention, interventions and outcomes Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Janet Leeds

South San Francisco (United States of America)

4 More presentations in this session

Presentation thumbnail
Discussant: Best Posters in prevention, interventions and outcomes
Presentation thumbnail
The impact of exercise volume on all-cause mortality, cardiovascular mortality and sudden cardiac arrest: a nationwide cohort study
Doctor Y. Park (Seoul, KR)
Abstract
Presentation thumbnail
Improvement in cardiovascular risk scores by a diet and exercise programme for obese and overweighted young adults
Mr R. Gascuena (Leganes, ES)
Abstract Slides
Presentation thumbnail
Score of adherence to 2016 european cardiovascular prevention guidelines is an independent determinant of cardiovascular and all-cause mortality in a french general population
Professor J. Ferrieres (Toulouse, FR)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 6 - Best Posters in prevention, interventions and outcomes

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources